CLINICAL_TRIALS trial_result · 2025-09-25

Clinical Trial Update: Dupilumab in Chinese Adult Participants With CRSwNP [Phase 3]

Phase 3 trial evaluating dupilumab in Chinese adults with chronic rhinosinusitis with nasal polyps has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: COMPLETED | Results posted: 2025-09-25